March 9, 2020 / 1:40 PM / a month ago

BRIEF-PAVmed Announces FDA 510(K) Re-Submission For Its Carpx Minimally Invasive Carpal Tunnel Device

March 9 (Reuters) - PAVmed Inc:

* PAVMED ANNOUNCES FDA 510(K) RE-SUBMISSION FOR ITS CARPX™ MINIMALLY INVASIVE CARPAL TUNNEL DEVICE

* PAVMED - CARPX 510(K) RE-SUBMISSION INCORPORATES DATA FROM CO’S FIRST-IN-HUMAN CARPX CLINICAL SAFETY STUDY

* PAVMED INC - ALL PATIENTS IN CO’S FIRST-IN-HUMAN CARPX CLINICAL SAFETY STUDY MET PRE-SPECIFIED SAFETY AND EFFECTIVENESS ENDPOINTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below